Improve mobility through physical activity

Trial ID
NCT06901869
Official Title
ActivPARK - Physical Activity in Persons With Parkinson's Disease- Pilot Study
Goal
Improve mobility through physical activity
Status
RECRUITING
Sponsor
Karolinska Institutet
Study Type
OBSERVATIONAL
Enrollment
50 participants
Conditions
Parkinson Disease, Physical Inactivity

Plain-Language Summary

ActivPARK wants to map how much and what kinds of physical activity people with Parkinson's actually do, and how activity levels link to symptoms and daily function so future exercise programs can be better targeted. The team will observe participants and collect activity and symptom data to chart real-world patterns, identify practical barriers, and pinpoint targets for later interventions. People diagnosed with Parkinson's at Hoehn and Yahr stages 1 to 4 can join, there are no age or sex limits, and the pilot plans to enroll about 50 participants.

Locations

  • Karolinska institutet, Stockholm, Solna, Sweden

Frequently Asked Questions

What is this trial testing?
This trial is studying an experimental treatment. ActivPARK wants to map how much and what kinds of physical activity people with Parkinson's actually do, and how activity levels link to symptoms and daily function so future exercise programs can be better targeted. The team will observe participants and collect activity and symptom data to chart real-world patterns, identify practical barriers, and pinpoint targets for later interventions. People diagnosed with Parkinson's at Hoehn and Yahr stages 1 to 4 can join, there are no age or sex limits, and the pilot plans to enroll about 50 participants.
Who can participate?
Eligibility criteria vary. Check the full listing on ClinicalTrials.gov for detailed inclusion and exclusion criteria.
Where is this trial located?
This trial is recruiting at 1 location.
Does it cost anything to join?
No. There is no cost to participate. Study-related care and treatment are provided at no charge.
How long does the trial last?
This trial is estimated to last approximately 1 year and 8 months.

View on ClinicalTrials.gov